Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study

NCT ID: NCT06472024

Last Updated: 2024-06-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-31

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if acupuncture can play a role in reducing pain and improving the quality of life of post-radiotherapy nasopharyngeal cancer mucositis patients. The main questions it aims to answer are:

\- Do manual acupuncture and medication therapy affect pain intensity as measured by the visual analogue scale (VAS) in patients with oral mucositis compared with sham manual acupuncture and medication?

Participants will receive acupuncture therapy 2 times a week for 3 weeks

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a clinical trial study to evaluate the role of acupuncture in pain relief and improving the quality of life of nasopharyngeal cancer patients with post-radiotherapy mucositis. Participants were 30 men/females with mucositis in post-radiotherapy nasopharyngeal cancer aged 19-59 years. They will be divided into 2 groups: (1) verum acupuncture and (2) sham acupuncture. Acupuncture is scheduled 2 times per week for 3 weeks. Research assessment on pain scale and improvement in quality of life

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Nasopharyngeal Carcinoma Mucositis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Verum Acupuncture

The verum acupuncture group will receive actual acupuncture therapy 2 times per week for 3 weeks

Group Type EXPERIMENTAL

Verum Acupuncture

Intervention Type PROCEDURE

Acupuncture therapy uses filiform needles at a perpendicular angle at acupuncture points to produce a therapeutic effect.

Sham Acupuncture

The Sham acupuncture group will receive Sham acupuncture therapy 2 times per week for 3 weeks

Group Type SHAM_COMPARATOR

Sham Acupuncture

Intervention Type PROCEDURE

Sham Acupuncture therapy uses filiform needles but is only attached with tape to acupuncture points

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Verum Acupuncture

Acupuncture therapy uses filiform needles at a perpendicular angle at acupuncture points to produce a therapeutic effect.

Intervention Type PROCEDURE

Sham Acupuncture

Sham Acupuncture therapy uses filiform needles but is only attached with tape to acupuncture points

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who have been proven by anatomical pathology examination to have a diagnosis of Nasopharyngeal Cancer.
* Subjects with adult Nasopharyngeal Cancer aged 19 years - 59 years.
* Nasopharyngeal Cancer Patients, who underwent bilateral Head and Neck radiotherapy.
* Patients diagnosed with mucositis.
* Willing to participate in the research until completion by signing an informed consent.

Exclusion Criteria

* Nasopharyngeal Cancer patients who have distant metastases (based on the Tumor Node Metastasis (TNM) classification with the presence of metastases (M1)).
* Subjects who still smoke and consume alcohol to date.
* Patients have contraindications for manual acupuncture, namely the use of anti-coagulant drugs, the presence of infection or wounds at the puncture site, emergency conditions, and pregnancy.
* There is a history of allergy to stainless steel materials.
* Patients with blood clotting disorders; Platelets \<50,000/μL, Absolute Neutrophil Count (ANC) \<1000/mm3, patients undergoing anticoagulant therapy with International Normalized Ratio (INR) \>2.47
Minimum Eligible Age

19 Years

Maximum Eligible Age

59 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indonesia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Imelda Dimara

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

KEPK FKUI-RSCM

Role: PRINCIPAL_INVESTIGATOR

The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Imelda Dimara, MD

Role: CONTACT

+6282319769944

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24-05-0717

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.